K912244Substantially Equivalent
Urotest Gph
In Wha Pharmaceutical Co., Ltd., Korea, KR / Traditional, Substantially Equivalent
K912244 is the FDA 510(k) clearance record for UROTEST GPH, a class II device, cleared for In Wha Pharmaceutical Co., Ltd. on under FDA product code JII (Atomic Absorption, Lithium). FDA records list one 510(k) clearance for In Wha Pharmaceutical Co., Ltd. As of , FDA records show no recalls naming K912244.
Clearance record
- Decision date
- Received
- (185 days to decision)
- Product code
- JII Atomic Absorption, Lithium
- Regulation
- 21 CFR 862.3560
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Applicant
- In Wha Pharmaceutical Co., Ltd. Buk-Ku Chungchun-Dong 234-1, Korea, KR
- 510(k) summary
- Statement
- Third party review
- No
Clearances, product code JII
Trailing 12 monthsFDA records hold no clearances under product code JII in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
